Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This clinical trial is studying how well surgery and/or combination chemotherapy with or
without radiation therapy or observation only work in treating young patients with newly
diagnosed stage I or stage II lymphocyte predominant Hodgkin disease (LPHD). Surgery may be
an effective treatment for LPHD. Drugs used in chemotherapy, such as doxorubicin,
vincristine, prednisone, and cyclophosphamide, work in different ways to stop the growth of
cancer cells, either by killing the cells or by stopping them from dividing. Radiation
therapy uses high-energy x-rays to kill cancer cells. Giving more than one drug (combination
chemotherapy) with or without radiation therapy may kill more cancer cells.